Table 3. Volumes, capacities and flows obtained and predicted for women and men without HAM/TSP.
| Women | P-value | Men | P-value | |||
|---|---|---|---|---|---|---|
| Variables | Obtained | Predicted | Obtained | Predicted | ||
| VC (L) | 2.69 ± 0.32 | 2.83 ± 032 | 0.10 | 4.26 ± 0.64 | 4.32 ± 0.31 | 0.88 |
| FVC (L) | 2.77 ± 0.40 | 2.83 ± 0.32 | 0.56 | 4.76 ± 0.76 | 4.32 ± 0.31 | 0.27 |
| FEV1 (L) | 2.34 ± 0.35 | 2.34 ± 0.30 | 0.92 | 3.81 ± 0.56 | 3.49 ± 0.21 | 0.34 |
| FEV1/CVF (%) | 84.26 ± 4.53 | 82.49 ± 1.88 | 0.20 | 79.74 ± 5.33 | 80.76 ± 2.07 | 0.71 |
| FEF25-75 (L/min) | 2.79 ± 0.76 | 2.4 ± 0.39 | 0.09 | 3.64 ± 0.76 | 3.34 ± 0.28 | 0.53 |
| FET25-75 (s) | 0.52 ± 0.13 | 0.57 ± 0.06 | 0.22 | 0.66 ± 0.13 | 0.61 ± 0.03 | 0.54 |
| FEFmáx (L/s) | 5.89 ± 1.22 | 6.55 ± 0.36 | 0.03* | 8.65 ± 0.63 | 10.6 ± 0.31 | 0.00* |
| FEF50% (L/s) | 3.53 ± 0.9 | 3.10 ± 0.37 | 0.10 | 4.63 ± 1.1 | 4.28 ± 0.27 | 0.56 |
| FEF75% (L/s) | 1.10 ± 0.39 | 0.90 ± 0.24 | 0.12 | 1.49 ± 0.49 | 1.24 ± 0.16 | 0.44 |
| MVV (L/min) | 85.66 ± 15.25 | 87.65 ± 27.26 | 0.73 | 139.9 ± 22 | 129.3 ± 8.06 | 0.40 |
Data are expressed as mean±standard deviation.
Paired Student's t test (p<0.05*).
Wilcoxon test (p<0.05*).
VC: vital capacity. FVC: forced vital capacity. FEV1: forced expiratory volume in one second. FEV1/CVF: ratio of forced expiratory volume in one second to forced vital capacity. FEF25-75%: 25%–75% forced expiratory flow. FEF25-75%/FVC: ratio of the 25%–75% forced expiratory flow and the forced vital capacity. FET25%-75%: 25%–75% forced expiratory time. FEFmáx: maximum forced expiratory flow. FEF50%: 505 forced expiratory flow. FEF75%: 75% forced expiratory flow. MMV: maximum voluntary ventilation. HAM/TSP: HTLV-1-associated myelopathy/tropical spastic paraparesis. L: liters. min: minute. s: second.